S
ABMD

Seeyond’s Abiomed Inc ABMD Stock Holding History

Seeyond’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,887
Closed -$954K – 620
2022
Q3 		$954K Sell
3,887
-209
-5% -$56.4K 0.12% 279
2022
Q2 		$1.01M Sell
4,096
-1,551
-27% -$419K 0.12% 305
2022
Q1 		$1.87M Buy
5,647
+1,589
+39% +$489K 0.19% 172
2021
Q4 		$1.46M Sell
4,058
-2,984
-42% -$1.01M 0.14% 252
2021
Q3 		$2.29M Sell
7,042
-71
-1% -$24.1K 0.22% 131
2021
Q2 		$2.22M Buy
7,113
+31
+0.4% +$9.51K 0.21% 148
2021
Q1 		$2.26M Sell
7,082
-1,289
-15% -$413K 0.23% 130
2020
Q4 		$2.71M Buy
8,371
+1,233
+17% +$341K 0.28% 76
2020
Q3 		$1.98M Buy
7,138
+3,083
+76% +$888K 0.21% 127
2020
Q2 		$980K Buy
4,055
+3,442
+562% +$691K 0.11% 264
2020
Q1 		$4.35M Sell
613
-3
-0.5% -$498 0.6% 29
2019
Q4 		$105K Hold
616
– – 0.01% 609
2019
Q3 		$110K Buy
616
+277
+82% +$59.9K 0.01% 583
2019
Q2 		$88K Sell
339
-73
-18% -$19.4K 0.01% 623
2019
Q1 		$118K Hold
412
– – 0.01% 593
2018
Q4 		$134K Buy
+412
New +$143K 0.02% 554

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Seeyond's ABMD Position: Q4 2022 in Review

Seeyond sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,887 shares — an estimated $954K sold.

Seeyond first reported a position in ABMD in Q4 2018 and held it in 16 quarters. The position peaked at $4.35M in Q1 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Seeyond reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Seeyond sold 3,887 Abiomed Inc shares in Q4 2022, an estimated $954K.
  • Seeyond first reported a position in Abiomed Inc in Q4 2018 and held it in 16 quarters.
  • Seeyond's Abiomed Inc position peaked at $4.35M in Q1 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.